Biological markers: Tailoring treatment and trials to prognosis

Biological markers: Tailoring treatment and trials to prognosis

Veure altres versions (1)

Dades bibliogràfiques
Autors principals:	Kerr, D, Shi, Y
Format:	Journal article
Idioma:	English
Publicat:	2013

Ítems similars

Biological markers: Tailoring treatment and trials to prognosis
per: Kerr, D, et al.
Publicat: (2013)

The Correlation Between Biological Markers and Prognosis in Thyroid Cancer
per: Rami Hajjar, et al.
Publicat: (2024-12-01)

Tailoring Biologic or Immunomodulator Treatment Withdrawal in Inflammatory Bowel Disease
per: Edouard Louis
Publicat: (2020-01-01)

Biological markers of favourable prognosis and successful pleurodesis for malignant pleural effusion
per: Psallidas, I, et al.
Publicat: (2016)

Tailored Biologics Selection in Severe Asthma
per: Sang Hyuk Kim, et al.
Publicat: (2024-01-01)

Mutation burden and other molecular markers of prognosis in the QUASAR2 clinical trial of colorectal cancer treated with curative intent
per: Domingo, E, et al.
Publicat: (2018)

Markers of oncological prognosis in the surgical treatment of oral squamous cell carcinoma
per: A. I. Stukan, et al.
Publicat: (2024-04-01)

NOVEL OPTICAL PROTEOMICS MOLECULARLY PROFILES BREAST CANCER PATIENTS LEADING TO INDIVIDUALISED PROGNOSIS AND TAILORED TREATMENT
per: Kelleher, M, et al.
Publicat: (2009)

MARKERS AND PROGNOSIS IN MULTIPLE-SCLEROSIS
per: Noseworthy, J, et al.
Publicat: (1983)

Tailor treatment to the patient in stable angina.
per: Taggart, D
Publicat: (2011)

Tailored carbon-based nanomaterials for biological energy electrocatalysis
per: Quinson, J
Publicat: (2015)

An evaluation of tailored psychological treatment of insomnia.
per: Espie, C, et al.
Publicat: (1989)

Identifying potential prognosis markers in hepatocellular carcinoma via integrated bioinformatics analysis and biological experiments
per: Xueting Hu, et al.
Publicat: (2022-07-01)

N7-methylguanosine methylation-related regulator genes as biological markers in predicting prognosis for melanoma
per: Jiehua Deng, et al.
Publicat: (2022-12-01)

Cost effectiveness of computer tailored and non-tailored smoking cessation letters in general practice: randomised controlled trial.
per: Lennox, A, et al.
Publicat: (2001)

Cost effectiveness of computer tailored and non-tailored smoking cessation letters in general practice: randomised controlled trial
per: Lennox, A, et al.
Publicat: (2001)

CAPS markers in plant biology
per: Y. N. Shavrukov
Publicat: (2015-07-01)

Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series
per: Domingo, E, et al.
Publicat: (2018)

Toward neuromarkers for tailored smoking cessation treatments
per: Francesco Versace, et al.
Publicat: (2023-06-01)

Tailoring surfaces : modifying surface composition and structure for applications in tribology, biology and catalysis /
per: 511742 Spencer, Nicholas D.
Publicat: (c201)

Single-cell analyses to tailor treatments
per: Benson, Mikael, et al.
Publicat: (2018)

Correction: Improving Nutrition and Activity Behaviors Using Digital Technology and Tailored Feedback: Protocol for the Tailored Diet and Activity (ToDAy) Randomized Controlled Trial
per: Halse, Rhiannon E, et al.
Publicat: (2020-12-01)

Computational design of anti-cancer peptides tailored to target specific tumor markers
per: Aisha Naeem, et al.
Publicat: (2024-02-01)

Cuproptosis-related lncRNAs and genes: Potential markers for glioblastoma prognosis and treatment.
per: Yajia Chen, et al.
Publicat: (2025-01-01)

New Biological Markers of Bone Metabolism in Osteoporosis Treatment
per: Sun Wook Cho
Publicat: (2016-09-01)

What is the role and impact of molecular markers on treatment decisions in the adjuvant setting of colorectal cancer?
per: Johnstone, E, et al.
Publicat: (2008)

The modified coughlin osteotomy for surgical treatment of high-grade tailor’s bunion
per: Shi-Ming Feng MD
Publicat: (2018-09-01)

Tailored nanocrystal catalysts
per: Zhao, Y
Publicat: (2023)

Tailoring Biologic Therapies for Pediatric Severe Asthma: A Comprehensive Approach
per: Claudia María Chaverri Repáraz, et al.
Publicat: (2025-01-01)

Tailoring two-dimensional nanomaterials by structural engineering for chemical and biological sensing
per: Bo Zhang, et al.
Publicat: (2020-11-01)

Tailored Base Surge Policy for Middle Echelon in Biologics Supply Chain
per: Pedroni, David
Publicat: (2022)

PB1811: BIOLOGIC AND CLINICAL SIGNIFICANCE OF CD7 ABERRANT EXPRESSION IN ACUTE MYELOID LEUKEMIA: A POOR PROGNOSIS MARKER
per: H. Charfi, et al.
Publicat: (2022-06-01)

Characterization of a Clinically and Biologically Defined Subgroup of Patients with Autism Spectrum Disorder and Identification of a Tailored Combination Treatment
per: Laura Pérez-Cano, et al.
Publicat: (2024-04-01)

Up-to-Date Tailored Systemic Treatment in Pancreatic Ductal Adenocarcinoma
per: Caroline Y. K. Fong, et al.
Publicat: (2019-01-01)

Prostate kallikrein markers in diagnosis, risk stratification and prognosis.
per: Ulmert, D, et al.
Publicat: (2009)

Pleomorphic Liposarcoma Unraveled: Investigating Histopathological and Immunohistochemical Markers for Tailored Diagnosis and Therapeutic Innovations
per: Ana-Maria Ciongariu, et al.
Publicat: (2024-06-01)

Tailoring treatment for locally advanced rectal cancer
per: Laudy Chehade, et al.
Publicat: (2024-01-01)

Commentary: Treatment for Truncus Arteriosus Needs to Be Tailored
per: Hong-Gook Lim
Publicat: (2023-03-01)

The genetics of myelodysplastic syndromes and the opportunities for tailored treatments
per: Christina-Nefeli Kontandreopoulou, et al.
Publicat: (2022-10-01)

Tailored liposomal nanotraps for the treatment of Streptococcal infections
per: Hervé Besançon, et al.
Publicat: (2021-02-01)